• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.60% Nasdaq Down0.80%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    119.81 Down 0.09(0.08%) 2:55PM EDT - Nasdaq Real Time Price
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
    Total Revenue 21,192   17,702   18,418   14,602  
    Cost of Revenue884  1,250  2,599  1,074  
    Gross Profit 20,308   16,452   15,819   13,528  
    Operating Expenses
    Research Development2,870  2,538  4,010  3,962  
    Selling General and Administrative6,188  4,971  7,225  5,994  
    Non Recurring234  345  218  223  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 11,016   8,598   4,366   3,349  
    Income from Continuing Operations
    Total Other Income/Expenses Net(158)3,786  21,767  (450)
    Earnings Before Interest And Taxes8,755  10,214  25,263  2,899  
    Interest Expense2,927  2,930  2,972  2,973  
    Income Before Tax5,828  7,284  22,291  (74)
    Income Tax Expense(2,620)(217,255)264  15  
    Minority Interest -   -  1,537  843  
    Net Income From Continuing Ops11,488  222,369  22,694  754  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 8,448   224,539   23,564   754  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 8,448   224,539   23,564   754  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.